Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells

Tumor Biology

Volumn 35, Issue 8, 2014, Pages 7965-7973

  Yang, Ning ^a   Hui, Lian ^a   Wang, Yan ^a   Yang, Huijun ^a   Jiang, Xuejun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

EMT process; Invasion; Migration; SOX2; Catenin

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HUMAN; LARYNX TUMOR; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; WNT SIGNALING PATHWAY;

BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84922393507     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2045-3     Document Type: Article

References (26)

1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559–64. doi:10.1126/science.1203543.
2. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895–904. doi:10.1038/nm1469.
3. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90. doi:10.1016/j.cell.2009.11.007.
4. Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T, et al. SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network. Cancer Lett. 2013;336(2):379–89. doi:10.1016/j.canlet.2013.03.027.
5. Galera-Ruiz H, Rios-Moreno MJ, Gonzalez-Campora R, Galera-Davidson H. WNT pathway in laryngeal squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otorhinolaryngol Ital Organo ufficiale della Societa italiana di Otorinolaringol Chir Cervicofac. 2012;32(2):122–3.
6. Fu Y, Zheng S, An N, Athanasopoulos T, Popplewell L, Liang A, et al. β-Catenin as a potential key target for tumor suppression. Int J Cancer. 2011;129(7):1541–51. doi:10.1002/ijc.26102.
7. Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J. 2012;31(12):2714–36. doi:10.1038/emboj.2012.150.
8. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41(11):1238–42. doi:10.1038/ng.465.
9. Tang XB, Shen XH, Li L, Zhang YF, Chen GQ. SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma. Auris Nasus Larynx. 2013;40(5):481–6. doi:10.1016/j.anl.2013.01.003.
10. Benelli R, Monteghirfo S, Vene R, Tosetti F, Ferrari N. The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability. Mol Cancer. 2010;9:142. doi:10.1186/1476-4598-9-142.
11. Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, et al. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One. 2012;7(5):e36326. doi:10.1371/journal.pone.0036326.
12. Shah JP, Karnell LH, Hoffman HT, Ariyan S, Brown GS, Fee WE, et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg. 1997;123(5):475–83.
13. Zhao XD, Zhang W, Liang HJ, Ji WY. Overexpression of miR-155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. PLoS One. 2013;8(2):e56395. doi:10.1371/journal.pone.0056395.
14. Pevny LH, Lovell-Badge R. Sox genes find their feet. Curr Opin Genet Dev. 1997;7(3):338–44.
15. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells. 2009;27(1):40–8. doi:10.1634/stemcells.2008-0493.
16. Lu Y, Futtner C, Rock JR, Xu X, Whitworth W, Hogan BL, et al. Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One. 2010;5(6):e11022. doi:10.1371/journal.pone.0011022.
17. Tung CL, Hou PH, Kao YL, Huang YW, Shen CC, Cheng YH, et al. SOX2 modulates alternative splicing in transitional cell carcinoma. Biochem Biophys Res Commun. 2010;393(3):420–5. doi:10.1016/j.bbrc.2010.02.010.
18. Bae KM, Su Z, Frye C, McClellan S, Allan RW, Andrejewski JT, et al. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol. 2010;183(5):2045–53. doi:10.1016/j.juro.2009.12.092.
19. Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas. 2006;32(2):164–70. doi:10.1097/01.mpa.0000202947.80117.a0.
20. Ye F, Li Y, Hu Y, Zhou C, Hu Y, Chen H. Expression of Sox2 in human ovarian epithelial carcinoma. J Cancer Res Clin Oncol. 2011;137(1):131–7. doi:10.1007/s00432-010-0867-y.
21. Xu XL, Xing BC, Han HB, Zhao W, Hu MH, Xu ZL, et al. The properties of tumor-initiating cells from a hepatocellular carcinoma patient’s primary and recurrent tumor. Carcinogenesis. 2010;31(2):167–74. doi:10.1093/carcin/bgp232.
22. Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, et al. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One. 2012;7(8):e41335. doi:10.1371/journal.pone.0041335.
23. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6):818–29. doi:10.1016/j.devcel.2008.05.009.
24. Polette M, Mestdagt M, Bindels S, Nawrocki-Raby B, Hunziker W, Foidart JM, et al. Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs. 2007;185(1–3):61–5. doi:10.1159/000101304.
25. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A. 2001;98(18):10356–61. doi:10.1073/pnas.171610498.
26. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem. 2008;283(26):17969–78. doi:10.1074/jbc.M802917200.